E-cigarettes and head and neck cancers: A systematic review of the current literature

Clinical Otolaryngology

Volumn 44, Issue 5, 2019, Pages 749-756

  Flach, Susanne ^a,b   Maniam, Pavithran ^c   Manickavasagam, Jaiganesh ^a  

^a NINEWELLS HOSPITAL   (United Kingdom)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^c UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

e cigarettes; electronic cigarettes; electronic nicotine delivery system; head and neck cancer; head and neck neoplasm; oral cancer; smoking

Indexed keywords

ARTICLE; CARCINOGENICITY; CELL MEDIATED CYTOTOXICITY; CLINICAL ASSESSMENT; DNA DAMAGE; HEAD AND NECK CANCER; HUMAN; LONG TERM EXPOSURE; OXIDATIVE STRESS; PREVALENCE; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; SYSTEMATIC REVIEW; ELECTRONIC CIGARETTE; GLOBAL HEALTH; HEAD AND NECK TUMOR; INCIDENCE; PROCEDURES; RISK ASSESSMENT; RISK FACTOR;

ELECTRONIC NICOTINE DELIVERY SYSTEMS; GLOBAL HEALTH; HEAD AND NECK NEOPLASMS; HUMANS; INCIDENCE; RISK ASSESSMENT; RISK FACTORS;

EID: 85069898165     PISSN: 17494478     EISSN: 17494486     Source Type: Journal    
DOI: 10.1111/coa.13384     Document Type: Article

References (59)

1. Cohen N, Fedewa S, Chen AY. Epidemiology and demographics of the head and neck cancer population. Oral Maxillofac Surg Clin North Am. 2018;30(4):381–395
2. Ferlay J, Colombet M, Soerjomataram I, et al. Cancer incidence and mortality patterns in Europe: Estimates for 40 countries and 25 major cancers in 2018. Eur J Cancer. 2018;103:356–387.
3. Henningfield JE, Zaatari GS. Electronic nicotine delivery systems: emerging science foundation for policy. Tob Control. 2010;19(2):89-90.
4. Action on Smoking and Health. ASH Factsheet. [Internet]. http://ash.org.uk. Accessed August 22, 2018.
5. Bullen C, Howe C, Laugesen M, et al. Electronic cigarettes for smoking cessation: a randomised controlled trial. The Lancet. 2013;16:1629-1637.
6. Caponnetto P, Campagna D, Cibella F, et al. EffiCiency and Safety of an eLectronic cigAreTte (ECLAT) as Tobacco Cigarettes Substitute: A Prospective 12-Month Randomized Control Design Study. Le Foll B, editor. PLoS ONE. Public Library of. Science. 2013;8(6):e66317-e66412.
7. Hartmann-Boyce J, McRobbie H, Bullen C, Begh R, Stead LF, Hajek P. Electronic cigarettes for smoking cessation. Hartmann-Boyce J, ed. Cochrane Syst Rev. Chichester, UK: John Wiley & Sons, Ltd; 2016;11(9):11220–11296.
8. Hajek P, Phillips-Waller A, Przulj D, et al. A Randomized Trial of E-Cigarettes versus Nicotine-Replacement Therapy. N Engl J Med. 2019;380(7):629–637.
9. Kalkhoran S, Glantz SA. E-cigarettes and smoking cessation in real-world and clinical settings: a systematic review and meta-analysis. Lancet Respir Med. 2016;4(2):116–128.
10. Bareham D, Ahmadi K, Elie M, Jones AW. E-cigarettes: controversies within the controversy. Lancet Respir. Elsevier Ltd. 2016;4(11):868–869.
11. Ganapathy V, Manyanga J, Brame L, et al. Electronic cigarette aerosols suppress cellular antioxidant defenses and induce significant oxidative DNA damage. PLoS ONE. 2017;12(5):e0177780.
12. Dinakar C, O'Connor GT. The Health Effects of Electronic Cigarettes. Longo DL, editor. N Engl J Med. 2016;375(14):1372–1381.
13. Zhu S-H, Sun JY, Bonnevie E, et al. Four hundred and sixty brands of e-cigarettes and counting: implications for product regulation. Tob Control. 2014;23:iii3–iii9.
14. Britton J, Arnott D, McNeill A, Hopkinson N. Tobacco Advisory Group of the Royal College of Physicians. Nicotine without smoke—putting electronic cigarettes in context. BMJ. 2016;353:i1745–i1754.
15. Medicines, Healthcare products Regulatory Agency. E-cigarettes: regulations for consumer products. https://www.gov.uk/guidance/e-cigarettes-regulations-for-consumer-products. 2016.
16. Lerner CA, Sundar IK, Yao H, et al. Vapors Produced by Electronic Cigarettes and E-Juices with Flavorings Induce Toxicity, Oxidative Stress, and Inflammatory Response in Lung Epithelial Cells and in Mouse Lung. Khan MF, editor. PLoS ONE. 2015;10(2):e0116732–e116826.
17. Sussan TE, Gajghate S, Thimmulappa RK, et al. Exposure to electronic cigarettes impairs pulmonary anti-bacterial and anti-viral defenses in a mouse model. Metzger DW, editor. PLoS ONE. 2015;10(2):e0116861–e116915.
18. Drope J, Cahn Z, Kennedy R, et al. Key issues surrounding the health impacts of electronic nicotine delivery systems (ENDS) and other sources of nicotine. CA Cancer J Clin. 2017;23(suppl 3):133–223.
19. Shields PG, Berman M, Brasky TM, et al. A review of pulmonary toxicity of electronic cigarettes in the context of smoking: a focus on inflammation. Cancer Epidemiol Biomarkers Prev. 2017;26(8):1175–1191.
20. Bourke L, Bauld L, Bullen C, et al. E-cigarettes and Urologic Health: A Collaborative Review of Toxicology, Epidemiology, and Potential Risks. Eur Urol. 2017;71(6):915–923.
21. Canistro D, Vivarelli F, Cirillo S et al. E-cigarettes induce toxicological effects that can raise the cancer risk. Sci Rep. Nature Publishing Group; 2017;7(1):786–789.
22. Lee H-W, Park S-H, Weng M-W, et al. E-cigarette smoke is potentially bladder carcinogenic - it induces tumorigenic DNA adducts and inhibits DNA repair in urothelial cells. J Urol. 2017;197:e913.
23. Fuller T, Acharya A, Bhaskar G, Yu M, Little S, Tarin T. Evaluation of e-cigarettes users urine for known bladder carcinogens. J Urol. 2017;197:e1179.
24. Dautzenberg B, Garelik D. Patients with lung cancer: Are electronic cigarettes harmful or useful? Lung Cancer. 2017;105:42–48.
25. Glasser AM, Collins L, Pearson JL, et al. Overview of Electronic Nicotine Delivery Systems: A Systematic Review. Am J Prev Med. 2017;52(2):e33–e66.
26. A systematic review of health effects of electronic cigarettes. World Health Organization. 2016;1–191.
27. Franco T, Trapasso S, Puzzo L, Allegra E. Electronic Cigarette: Role in the Primary Prevention of Oral Cavity Cancer. Clin Med Insights Ear, Nose Throat. 2016;9:CMENT.S40364
28. Rowell TR, Tarran R. Will chronic e-cigarette use cause lung disease? Am J Physiol Lung Cell Mol Physiol. 2015;309(12):L1398–L1409.
29. McCauley L, Markin C, An HD. Unexpected consequence of electronic cigarette use. Chest. 2012;141(4):1110–1113.
30. Moher D, Liberati A, Tetzlaff J, Altman DG, for the PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ. 2009;339(jul21 1):b2535–b2545.
31. Howick J, Chalmers I, Glasziou P, Greenhalgh T, Heneghan C, Alessandro L, et al. The Oxford Levels of Evidence 2. https://www.cebm.net/2016/05/ocebm-levels-of-evidence/
32. Ji EH, Sun B, Zhao T, et al. Characterization of Electronic Cigarette Aerosol and Its Induction of Oxidative Stress Response in Oral Keratinocytes. PLoS ONE. Teh M-T, editor. Public Library of Science. 2016;11(5):e0154447–e154513.
33. Hwang JH, Lyes M, Sladewski K, et al. Electronic cigarette inhalation alters innate immunity and airway cytokines while increasing the virulence of colonizing bacteria. J Mol Med. Springer, Berlin Heidelberg. 2016;94(6):667–679.
34. Sancilio S, Gallorini M, Cataldi A, di Giacomo V. Cytotoxicity and apoptosis induction by e-cigarette fluids in human gingival fibroblasts. Clin Oral Invest. 2015;20(3):477–483.
35. Rouabhia M, Park HJ, Semlali A, Zakrzewski A, Chmielewski W, Chakir J. E-Cigarette Vapor Induces an Apoptotic Response in Human Gingival Epithelial Cells Through the Caspase-3 Pathway. J Cell Physiol. Wiley-Blackwell. 2016;232(6):1539–1547.
36. Willershausen I, Wolf T, Weyer V, Sader R, Ghanaati S, Willershausen B. Influence of E-smoking liquids on human periodontal ligament fibroblasts. Head Face Med. 2014;10(1):1–7. https://doi.org/10.1186/1746-160X-10-39.
37. Sundar IK, Javed F, Romanos G, Rahman I. E-cigarettes and flavorings induce inflammatory and pro-senescence responses in oral epithelial cells and periodontal fibroblasts. Oncotarget. 2016;7:77196–77204.
38. Korrapati A, Yu V, Saad MA, et al. Abstract 4069: The carcinogenic effects of electronic cigarettes in oral cancer. AACR: New Orleans, LA, Philadelphia (PA); 2016.
39. Wisniewski DJ, Ma T, Schneider A. Nicotine induces oral dysplastic keratinocyte migration via fatty acid synthase-dependent epidermal growth factor receptor activation. Exp Cell Res. Elsevier Inc; 2018;370(2):343–352.
40. Yu V, Rahimy M, Korrapati A, et al. Electronic cigarettes induce DNA strand breaks and cell death independently of nicotine in cell lines. Oral Oncol. 2016;52:58–65.
41. Song J-J, Go YY, Mun JY, et al. Effect of electronic cigarettes on human middle ear. Int J Pediatr Otorhinolaryngol. 2018;109:67–71.
42. Welz C, Canis M, Schwenk-Zieger S et al. Cytotoxic and Genotoxic Effects of Electronic Cigarette Liquids on Human Mucosal Tissue Cultures of the Oropharynx. J Environ Pathol Toxicol Oncol. Begel House Inc; 2016;35(4):343–354.
43. Salturk Z, Çakır Ç, Sünnetçi G, et al. Effects of electronic nicotine delivery system on larynx: experimental study. J Voice. Elsevier Ltd. 2015;29(5):560–563.
44. Reuther WJ, Hale B, Matharu J, Blythe JN, Brennan PA. Do you mind if I vape? Immediate effects of electronic cigarettes on perfusion in buccal mucosal tissue - a pilot study. Br J Oral Maxillofac Surg. British Association of Oral and Maxillofacial Surgeons. 2016;54(3):338–341.
45. Bardellini E, Amadori F, Conti G, Majorana A. Oral mucosal lesions in electronic cigarettes consumers versus former smokers. Acta Odontol Scand. Informa UK Limited, trading as Taylor & Francis Group; 2018;76(3):226–228.
46. Bustamante G, Ma B, Yakovlev G, et al. Presence of the Carcinogen N′-Nitrosonornicotine in Saliva of E-cigarette Users. Chemical Research in Toxicology. Am Chem Soc. 2018;31(8):731–738.
47. Nguyen H, Kitzmiller JP, Nguyen KT, Nguyen CD, Chi BT. Oral Carcinoma Associated with Chronic Use of Electronic Cigarettes. Otolaryngol (Sunnyvale). 2017;07(02):1–3.
48. Cheng T. Chemical evaluation of electronic cigarettes. Tob Control. BMJ Publishing Group Ltd; 2014;23(suppl 2):ii11–ii17.
49. Kosmider L, Sobczak A, Fik M, et al. Carbonyl Compounds in Electronic Cigarette Vapors: Effects of Nicotine Solvent and Battery Output Voltage. NICTOB. 2014;16(10):1319–1326.
50. Williams M, Villarreal A, Bozhilov K, Lin S, Talbot P. Metal and silicate particles including nanoparticles are present in electronic cigarette cartomizer fluid and aerosol. Johnson SJ, editor. PLoS ONE. Public Library of Science. 2013;8(3):e57987–e58011.
51. Gaur S, Agnihotri R. Health effects of trace metals in electronic cigarette aerosols—a systematic Review. Biol Trace Elem Res. 2019;188(2):295–315.
52. Jensen RP, Luo W, Pankow JF, Strongin RM, Peyton DH. Hidden Formaldehyde in E-Cigarette Aerosols. N Engl J Med. 2015;372(4):389–392.
53. Zborovskaya Y. E-Cigarettes and Smoking Cessation: A Primer for Oncology Clinicians. Clin J Oncol Nurs. 2017;21(1):54–63.
54. Holliday R, Kist R, Bauld L. E-cigarette vapour is not inert and exposure can lead to cell damage. Evid Based Dent. Nature Publishing Group. Nature Publishing Group; 2016;17(1):2–3.
55. Barrington-Trimis JL, Leventhal AM. Adolescents' Use of ‘Pod Mod’ E-Cigarettes - Urgent Concerns. N Engl J Med. 2018;379(12):1099–1102.
56. Korfei M. The underestimated danger of E-cigarettes - also in the absence of nicotine. Respir Res. 2018;19(1):63–64.
57. Lee H-W, Park S-H, Weng M-W, et al. E-cigarette smoke damages DNA and reduces repair activity in mouse lung, heart, and bladder as well as in human lung and bladder cells. PNAS. National Academy of Sciences. 2018;115(7):E1560–E1569.
58. Zahedi A, Phandthong R, Chaili A, Remark G, Talbot P. Epithelial-to-mesenchymal transition of A549 lung cancer cells exposed to electronic cigarettes. Lung Cancer. 2018;122:224–233.
59. Fuller TW, Acharya AP, Meyyappan T, et al. Comparison of bladder carcinogens in the urine of E-cigarette users versus non E-cigarette using controls. Sci Rep. 2018;8(1):187–196.